Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid (Q28375638)

0 references

F Albertioni

0 references

I Vassilaki

0 references

C Peterson

0 references

E Stephansson

Journal of the American Academy of Dermatology

0 references

language of work or name

English

0 references

publication date

May 1999

0 references

published in

0 references

volume

0 references

issue

5 Pt 1

0 references

page(s)

741-9

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Lack of predictive factors for the clinical course of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Low-dose methotrexate treatment in elderly patients with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

The pharmacology of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Methotrexate guidelines--revised

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

IN-VIVO SEPARATION OF EPIDERMIS BY PRODUCTION OF SUCTION BLISTERS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Simultaneous quantitation of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Synthesis and biologic evaluation of 7-hydroxymethotrexate, 7-methylaminopterin, and 7-methylmethotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Blood eosinophilia as a severity marker for bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Methotrexate interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021

Cytotoxic agents for use in dermatology. I.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970156-8

7 January 2021